Two-day virtual meeting brought together stakeholders from academia, government, and industry to discuss challenges related to antimicrobial stewardship during the COVID-19 pandemic.

Research team led by Dr. Peter Doshi finds many clinical trials for antibiotics fail to communicate the trial’s purpose to study participants.